Shengping Li
Impact in
- Biotechnology top 2%
- Microbial Inactivation Methods
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 31
- Pancreatic and Hepatic Oncology Research 22
- Cancer Immunotherapy and Biomarkers 6
-
- Microbial Inactivation Methods 15
- Co-authors
- Chaobin He (31 shared papers)Xiaojun Lin (17 shared papers)Shuxin Sun (15 shared papers)Xin Huang (15 shared papers)Yu Zhang (9 shared papers)Xiang‐Ming Lao (9 shared papers)Yize Mao (16 shared papers)Alfred E. Chang (2 shared papers)
- Journals
- Frontiers in Oncology (7 papers)BMC Cancer (4 papers)Journal of Inflammation Research (4 papers)Pancreatology (3 papers)Journal of Cancer (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shengping Li
83 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Biotechnology 233
- Oncology 551
- Hepatology 143
- Cancer Research 239
- Immunology 333
Countries citing papers authored by Shengping Li
This map shows the geographic impact of Shengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengping Li more than expected).
Fields of papers citing papers by Shengping Li
This network shows the impact of papers produced by Shengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengping Li. The network helps show where Shengping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 126 | |
| 2 | 2012 | 95 | |
| 3 | 2017 | 85 | |
| 4 | 2011 | 75 | |
| 5 | 2013 | 65 | |
| 6 | 2012 | 64 | |
| 7 | 2020 | 62 | |
| 8 | 2020 | 60 | |
| 9 | 2021 | 59 | |
| 10 | 2013 | 53 | |
| 11 | 2015 | 48 | |
| 12 | 2019 | 42 | |
| 13 | 2018 | 42 | |
| 14 | 2012 | 40 | |
| 15 | 2021 | 39 | |
| 16 | 2021 | 35 | |
| 17 | 2016 | 35 | |
| 18 | 2011 | 32 | |
| 19 | 2018 | 32 | |
| 20 | 2019 | 31 |
About Shengping Li
Shengping Li is a scholar working on Oncology, Biotechnology, Molecular Biology, Epidemiology and Cancer Research, having authored 85 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (22 papers), Microbial Inactivation Methods (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Advanced Sensor and Energy Harvesting Materials (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Genomics and Diagnostics (5 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Biotechnology (233 citations), Oncology (551 citations), Hepatology (143 citations), Cancer Research (239 citations) and Immunology (333 citations). Shengping Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Chaobin He, Xiaojun Lin, Shuxin Sun, Xin Huang, Yu Zhang, Xiang‐Ming Lao, Yize Mao, Alfred E. Chang, Hua Tang and Zhiyuan Cai. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Journal of Inflammation Research, Pancreatology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.